img

Global Gosling Plague Vaccine Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Agriculture

Publisher : MRA | Format : PDF

Global Gosling Plague Vaccine Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Gosling Plague Vaccine report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Gosling Plague Vaccine market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Demand from Individual Farming and Medium and Large Farms are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Gosling Plague Vaccine industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Gosling Plague Vaccine key manufacturers include Qingdao Vland Biotech, Harbin Pharmaceutical Group, Sinopharm-Vacbio, JinYu Biotechnology Co., Ltd. and Jilin Zhengye Biological Product, etc. Qingdao Vland Biotech, Harbin Pharmaceutical Group, Sinopharm-Vacbio are top 3 players and held % sales share in total in 2022.
Gosling Plague Vaccine can be divided into Live Attenuated Vaccines and Inactivated Vaccines, etc. Live Attenuated Vaccines is the mainstream product in the market, accounting for % sales share globally in 2022.
Gosling Plague Vaccine is widely used in various fields, such as Individual Farming and Medium and Large Farms, etc. Individual Farming provides greatest supports to the Gosling Plague Vaccine industry development. In 2022, global % sales of Gosling Plague Vaccine went into Individual Farming filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Gosling Plague Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Qingdao Vland Biotech
Harbin Pharmaceutical Group
Sinopharm-Vacbio
JinYu Biotechnology Co., Ltd.
Jilin Zhengye Biological Product
Segment by Type
Live Attenuated Vaccines
Inactivated Vaccines

Segment by Application


Individual Farming
Medium and Large Farms

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Gosling Plague Vaccine market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Gosling Plague Vaccine, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Gosling Plague Vaccine industry.
Chapter 3Historical (2018-2022) and forecast (2023-2033) volume and revenue analysis of Gosling Plague Vaccine in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Gosling Plague Vaccine introduction, etc. Gosling Plague Vaccine Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13MRAResearch’s Conclusions of Gosling Plague Vaccine market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by MRAResearch.

Table of Content

1 Gosling Plague Vaccine Market Overview
1.1 Gosling Plague Vaccine Product Overview
1.2 Gosling Plague Vaccine Market Segment by Type
1.2.1 Live Attenuated Vaccines
1.2.2 Inactivated Vaccines
1.3 Global Gosling Plague Vaccine Market Size by Type
1.3.1 Global Gosling Plague Vaccine Market Size Overview by Type (2018-2033)
1.3.2 Global Gosling Plague Vaccine Historic Market Size Review by Type (2018-2023)
1.3.3 Global Gosling Plague Vaccine Forecasted Market Size by Type (2024-2033)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Gosling Plague Vaccine Sales Breakdown by Type (2018-2023)
1.4.2 Europe Gosling Plague Vaccine Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Gosling Plague Vaccine Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Gosling Plague Vaccine Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Gosling Plague Vaccine Sales Breakdown by Type (2018-2023)
2 Global Gosling Plague Vaccine Market Competition by Company
2.1 Global Top Players by Gosling Plague Vaccine Sales (2018-2023)
2.2 Global Top Players by Gosling Plague Vaccine Revenue (2018-2023)
2.3 Global Top Players by Gosling Plague Vaccine Price (2018-2023)
2.4 Global Top Manufacturers Gosling Plague Vaccine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Gosling Plague Vaccine Market Competitive Situation and Trends
2.5.1 Gosling Plague Vaccine Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Gosling Plague Vaccine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Gosling Plague Vaccine as of 2022)
2.7 Date of Key Manufacturers Enter into Gosling Plague Vaccine Market
2.8 Key Manufacturers Gosling Plague Vaccine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Gosling Plague Vaccine Status and Outlook by Region
3.1 Global Gosling Plague Vaccine Market Size and CAGR by Region: 2018 VS 2022 VS 2033
3.2 Global Gosling Plague Vaccine Historic Market Size by Region
3.2.1 Global Gosling Plague Vaccine Sales in Volume by Region (2018-2023)
3.2.2 Global Gosling Plague Vaccine Sales in Value by Region (2018-2023)
3.2.3 Global Gosling Plague Vaccine Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Gosling Plague Vaccine Forecasted Market Size by Region
3.3.1 Global Gosling Plague Vaccine Sales in Volume by Region (2024-2033)
3.3.2 Global Gosling Plague Vaccine Sales in Value by Region (2024-2033)
3.3.3 Global Gosling Plague Vaccine Sales (Volume & Value), Price and Gross Margin (2024-2033)
4 Global Gosling Plague Vaccine by Application
4.1 Gosling Plague Vaccine Market Segment by Application
4.1.1 Individual Farming
4.1.2 Medium and Large Farms
4.2 Global Gosling Plague Vaccine Market Size by Application
4.2.1 Global Gosling Plague Vaccine Market Size Overview by Application (2018-2033)
4.2.2 Global Gosling Plague Vaccine Historic Market Size Review by Application (2018-2023)
4.2.3 Global Gosling Plague Vaccine Forecasted Market Size by Application (2024-2033)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Gosling Plague Vaccine Sales Breakdown by Application (2018-2023)
4.3.2 Europe Gosling Plague Vaccine Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Gosling Plague Vaccine Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Gosling Plague Vaccine Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Gosling Plague Vaccine Sales Breakdown by Application (2018-2023)
5 North America Gosling Plague Vaccine by Country
5.1 North America Gosling Plague Vaccine Historic Market Size by Country
5.1.1 North America Gosling Plague Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2033
5.1.2 North America Gosling Plague Vaccine Sales in Volume by Country (2018-2023)
5.1.3 North America Gosling Plague Vaccine Sales in Value by Country (2018-2023)
5.2 North America Gosling Plague Vaccine Forecasted Market Size by Country
5.2.1 North America Gosling Plague Vaccine Sales in Volume by Country (2024-2033)
5.2.2 North America Gosling Plague Vaccine Sales in Value by Country (2024-2033)
6 Europe Gosling Plague Vaccine by Country
6.1 Europe Gosling Plague Vaccine Historic Market Size by Country
6.1.1 Europe Gosling Plague Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2033
6.1.2 Europe Gosling Plague Vaccine Sales in Volume by Country (2018-2023)
6.1.3 Europe Gosling Plague Vaccine Sales in Value by Country (2018-2023)
6.2 Europe Gosling Plague Vaccine Forecasted Market Size by Country
6.2.1 Europe Gosling Plague Vaccine Sales in Volume by Country (2024-2033)
6.2.2 Europe Gosling Plague Vaccine Sales in Value by Country (2024-2033)
7 Asia-Pacific Gosling Plague Vaccine by Region
7.1 Asia-Pacific Gosling Plague Vaccine Historic Market Size by Region
7.1.1 Asia-Pacific Gosling Plague Vaccine Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2033
7.1.2 Asia-Pacific Gosling Plague Vaccine Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Gosling Plague Vaccine Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Gosling Plague Vaccine Forecasted Market Size by Region
7.2.1 Asia-Pacific Gosling Plague Vaccine Sales in Volume by Region (2024-2033)
7.2.2 Asia-Pacific Gosling Plague Vaccine Sales in Value by Region (2024-2033)
8 Latin America Gosling Plague Vaccine by Country
8.1 Latin America Gosling Plague Vaccine Historic Market Size by Country
8.1.1 Latin America Gosling Plague Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2033
8.1.2 Latin America Gosling Plague Vaccine Sales in Volume by Country (2018-2023)
8.1.3 Latin America Gosling Plague Vaccine Sales in Value by Country (2018-2023)
8.2 Latin America Gosling Plague Vaccine Forecasted Market Size by Country
8.2.1 Latin America Gosling Plague Vaccine Sales in Volume by Country (2024-2033)
8.2.2 Latin America Gosling Plague Vaccine Sales in Value by Country (2024-2033)
9 Middle East and Africa Gosling Plague Vaccine by Country
9.1 Middle East and Africa Gosling Plague Vaccine Historic Market Size by Country
9.1.1 Middle East and Africa Gosling Plague Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2033
9.1.2 Middle East and Africa Gosling Plague Vaccine Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Gosling Plague Vaccine Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Gosling Plague Vaccine Forecasted Market Size by Country
9.2.1 Middle East and Africa Gosling Plague Vaccine Sales in Volume by Country (2024-2033)
9.2.2 Middle East and Africa Gosling Plague Vaccine Sales in Value by Country (2024-2033)
10 Company Profiles
10.1 Qingdao Vland Biotech
10.1.1 Qingdao Vland Biotech Company Information
10.1.2 Qingdao Vland Biotech Introduction and Business Overview
10.1.3 Qingdao Vland Biotech Gosling Plague Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Qingdao Vland Biotech Gosling Plague Vaccine Products Offered
10.1.5 Qingdao Vland Biotech Recent Development
10.2 Harbin Pharmaceutical Group
10.2.1 Harbin Pharmaceutical Group Company Information
10.2.2 Harbin Pharmaceutical Group Introduction and Business Overview
10.2.3 Harbin Pharmaceutical Group Gosling Plague Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Harbin Pharmaceutical Group Gosling Plague Vaccine Products Offered
10.2.5 Harbin Pharmaceutical Group Recent Development
10.3 Sinopharm-Vacbio
10.3.1 Sinopharm-Vacbio Company Information
10.3.2 Sinopharm-Vacbio Introduction and Business Overview
10.3.3 Sinopharm-Vacbio Gosling Plague Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Sinopharm-Vacbio Gosling Plague Vaccine Products Offered
10.3.5 Sinopharm-Vacbio Recent Development
10.4 JinYu Biotechnology Co., Ltd.
10.4.1 JinYu Biotechnology Co., Ltd. Company Information
10.4.2 JinYu Biotechnology Co., Ltd. Introduction and Business Overview
10.4.3 JinYu Biotechnology Co., Ltd. Gosling Plague Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.4.4 JinYu Biotechnology Co., Ltd. Gosling Plague Vaccine Products Offered
10.4.5 JinYu Biotechnology Co., Ltd. Recent Development
10.5 Jilin Zhengye Biological Product
10.5.1 Jilin Zhengye Biological Product Company Information
10.5.2 Jilin Zhengye Biological Product Introduction and Business Overview
10.5.3 Jilin Zhengye Biological Product Gosling Plague Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Jilin Zhengye Biological Product Gosling Plague Vaccine Products Offered
10.5.5 Jilin Zhengye Biological Product Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Gosling Plague Vaccine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Gosling Plague Vaccine Industrial Chain Analysis
11.4 Gosling Plague Vaccine Market Dynamics
11.4.1 Gosling Plague Vaccine Industry Trends
11.4.2 Gosling Plague Vaccine Market Drivers
11.4.3 Gosling Plague Vaccine Market Challenges
11.4.4 Gosling Plague Vaccine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Gosling Plague Vaccine Distributors
12.3 Gosling Plague Vaccine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Live Attenuated Vaccines
Table 2. Major Company of Inactivated Vaccines
Table 3. Global Gosling Plague Vaccine Sales by Type 2018 VS 2022 VS 2033 (US$ Million)
Table 4. Global Gosling Plague Vaccine Sales by Type (2018-2023) & (M Doses)
Table 5. Global Gosling Plague Vaccine Sales Market Share in Volume by Type (2018-2023)
Table 6. Global Gosling Plague Vaccine Sales by Type (2018-2023) & (US& Million)
Table 7. Global Gosling Plague Vaccine Market Share in Value by Type (2018-2023)
Table 8. Global Gosling Plague Vaccine Price by Type (2018-2023) & (US$/K Doses)
Table 9. Global Gosling Plague Vaccine Sales by Type (2024-2033) & (M Doses)
Table 10. Global Gosling Plague Vaccine Sales Market Share in Volume by Type (2024-2033)
Table 11. Global Gosling Plague Vaccine Sales by Type (2024-2033) & (US$ Million)
Table 12. Global Gosling Plague Vaccine Sales Market Share in Value by Type (2024-2033)
Table 13. Global Gosling Plague Vaccine Price by Type (2024-2033) & (US$/K Doses)
Table 14. North America Gosling Plague Vaccine Sales by Type (2018-2023) & (M Doses)
Table 15. North America Gosling Plague Vaccine Sales by Type (2018-2023) & (US$ Million)
Table 16. Europe Gosling Plague Vaccine Sales (M Doses) by Type (2018-2023)
Table 17. Europe Gosling Plague Vaccine Sales by Type (2018-2023) & (US$ Million)
Table 18. Asia-Pacific Gosling Plague Vaccine Sales (M Doses) by Type (2018-2023)
Table 19. Asia-Pacific Gosling Plague Vaccine Sales by Type (2018-2023) & (US$ Million)
Table 20. Latin America Gosling Plague Vaccine Sales (M Doses) by Type (2018-2023)
Table 21. Latin America Gosling Plague Vaccine Sales by Type (2018-2023) & (US$ Million)
Table 22. Middle East and Africa Gosling Plague Vaccine Sales (M Doses) by Type (2018-2023)
Table 23. Middle East and Africa Gosling Plague Vaccine Sales by Type (2018-2023) & (US$ Million)
Table 24. Global Gosling Plague Vaccine Sales by Company (2018-2023) & (M Doses)
Table 25. Global Gosling Plague Vaccine Sales Share by Company (2018-2023)
Table 26. Global Gosling Plague Vaccine Revenue by Company (2018-2023) & (US$ Million)
Table 27. Global Gosling Plague Vaccine Revenue Share by Company (2018-2023)
Table 28. Global Market Gosling Plague Vaccine Price by Company (2018-2023) & (US$/K Doses)
Table 29. Global Gosling Plague Vaccine Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Gosling Plague Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Gosling Plague Vaccine as of 2022)
Table 32. Date of Key Manufacturers Enter into Gosling Plague Vaccine Market
Table 33. Key Manufacturers Gosling Plague Vaccine Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Gosling Plague Vaccine Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2033
Table 36. Global Gosling Plague Vaccine Sales by Region (2018-2023) & (M Doses)
Table 37. Global Gosling Plague Vaccine Sales Market Share in Volume by Region (2018-2023)
Table 38. Global Gosling Plague Vaccine Sales by Region (2018-2023) & (US$ Million)
Table 39. Global Gosling Plague Vaccine Sales Market Share in Value by Region (2018-2023)
Table 40. Global Gosling Plague Vaccine Sales (M Doses), Revenue (US$ Million), Price (US$/K Doses) and Gross Margin (2018-2023)
Table 41. Global Gosling Plague Vaccine Sales by Region (2024-2033) & (M Doses)
Table 42. Global Gosling Plague Vaccine Sales Market Share in Volume by Region (2024-2033)
Table 43. Global Gosling Plague Vaccine Sales by Region (2024-2033) & (US$ Million)
Table 44. Global Gosling Plague Vaccine Sales Market Share in Value by Region (2024-2033)
Table 45. Global Gosling Plague Vaccine Sales (M Doses), Revenue (US$ Million), Price (US$/K Doses) and Gross Margin (2024-2033)
Table 46. Global Gosling Plague Vaccine Sales by Application: 2018 VS 2022 VS 2033 (US$ Million)
Table 47. Global Gosling Plague Vaccine Sales by Application (2018-2023) & (M Doses)
Table 48. Global Gosling Plague Vaccine Sales Market Share in Volume by Application (2018-2023)
Table 49. Global Gosling Plague Vaccine Sales by Application (2018-2023) & (US$ Million)
Table 50. Global Gosling Plague Vaccine Sales Market Share in Value by Application (2018-2023)
Table 51. Global Gosling Plague Vaccine Price by Application (2018-2023) & (US$/K Doses)
Table 52. Global Gosling Plague Vaccine Sales by Application (2024-2033) & (M Doses)
Table 53. Global Gosling Plague Vaccine Sales Market Share in Volume by Application (2024-2033)
Table 54. Global Gosling Plague Vaccine Sales by Application (2024-2033) & (US$ Million)
Table 55. Global Gosling Plague Vaccine Sales Market Share in Value by Application (2024-2033)
Table 56. Global Gosling Plague Vaccine Price by Application (2024-2033) & (US$/K Doses)
Table 57. North America Gosling Plague Vaccine Sales by Application (2018-2023) (M Doses)
Table 58. North America Gosling Plague Vaccine Sales by Application (2018-2023) & (US$ Million)
Table 59. Europe Gosling Plague Vaccine Sales by Application (2018-2023) (M Doses)
Table 60. Europe Gosling Plague Vaccine Sales by Application (2018-2023) & (US$ Million)
Table 61. Asia-Pacific Gosling Plague Vaccine Sales by Application (2018-2023) (M Doses)
Table 62. Asia-Pacific Gosling Plague Vaccine Sales by Application (2018-2023) & (US$ Million)
Table 63. Latin America Gosling Plague Vaccine Sales by Application (2018-2023) (M Doses)
Table 64. Latin America Gosling Plague Vaccine Sales by Application (2018-2023) & (US$ Million)
Table 65. Middle East and Africa Gosling Plague Vaccine Sales by Application (2018-2023) (M Doses)
Table 66. Middle East and Africa Gosling Plague Vaccine Sales by Application (2018-2023) & (US$ Million)
Table 67. North America Gosling Plague Vaccine Sales by Country (2018-2023) & (M Doses)
Table 68. North America Gosling Plague Vaccine Sales Market Share in Volume by Country (2018-2023)
Table 69. North America Gosling Plague Vaccine Sales by Country (2018-2023) & (US$ Million)
Table 70. North America Gosling Plague Vaccine Sales Market Share in Value by Country (2018-2023)
Table 71. North America Gosling Plague Vaccine Sales by Country (2024-2033) & (M Doses)
Table 72. North America Gosling Plague Vaccine Sales Market Share in Volume by Country (2024-2033)
Table 73. North America Gosling Plague Vaccine Sales by Country (2024-2033) & (US$ Million)
Table 74. North America Gosling Plague Vaccine Sales Market Share in Value by Country (2024-2033)
Table 75. Europe Gosling Plague Vaccine Sales by Country (2018-2023) & (M Doses)
Table 76. Europe Gosling Plague Vaccine Sales Market Share in Volume by Country (2018-2023)
Table 77. Europe Gosling Plague Vaccine Sales by Country (2018-2023) & (US$ Million)
Table 78. Europe Gosling Plague Vaccine Sales Market Share in Value by Country (2018-2023)
Table 79. Europe Gosling Plague Vaccine Sales by Country (2024-2033) & (M Doses)
Table 80. Europe Gosling Plague Vaccine Sales Market Share in Volume by Country (2024-2033)
Table 81. Europe Gosling Plague Vaccine Sales by Country (2024-2033) & (US$ Million)
Table 82. Europe Gosling Plague Vaccine Sales Market Share in Value by Country (2024-2033)
Table 83. Asia-Pacific Gosling Plague Vaccine Sales by Region (2018-2023) & (M Doses)
Table 84. Asia-Pacific Gosling Plague Vaccine Sales Market Share in Volume by Region (2018-2023)
Table 85. Asia-Pacific Gosling Plague Vaccine Sales by Region (2018-2023) & (US$ Million)
Table 86. Asia-Pacific Gosling Plague Vaccine Sales Market Share in Value by Region (2018-2023)
Table 87. Asia-Pacific Gosling Plague Vaccine Sales by Region (2024-2033) & (M Doses)
Table 88. Asia-Pacific Gosling Plague Vaccine Sales Market Share in Volume by Region (2024-2033)
Table 89. Asia-Pacific Gosling Plague Vaccine Sales by Region (2024-2033) & (US$ Million)
Table 90. Asia-Pacific Gosling Plague Vaccine Sales Market Share in Value by Region (2024-2033)
Table 91. Latin America Gosling Plague Vaccine Sales by Country (2018-2023) & (M Doses)
Table 92. Latin America Gosling Plague Vaccine Sales Market Share in Volume by Country (2018-2023)
Table 93. Latin America Gosling Plague Vaccine Sales by Country (2018-2023) & (US$ Million)
Table 94. Latin America Gosling Plague Vaccine Sales Market Share in Value by Country (2018-2023)
Table 95. Latin America Gosling Plague Vaccine Sales by Country (2024-2033) & (M Doses)
Table 96. Latin America Gosling Plague Vaccine Sales Market Share in Volume by Country (2024-2033)
Table 97. Latin America Gosling Plague Vaccine Sales by Country (2024-2033) & (US$ Million)
Table 98. Latin America Gosling Plague Vaccine Sales Market Share in Value by Country (2024-2033)
Table 99. Middle East and Africa Gosling Plague Vaccine Sales by Country (2018-2023) & (M Doses)
Table 100. Middle East and Africa Gosling Plague Vaccine Sales Market Share in Volume by Country (2018-2023)
Table 101. Middle East and Africa Gosling Plague Vaccine Sales by Country (2018-2023) & (US$ Million)
Table 102. Middle East and Africa Gosling Plague Vaccine Sales Market Share in Value by Country (2018-2023)
Table 103. Middle East and Africa Gosling Plague Vaccine Sales by Country (2024-2033) & (M Doses)
Table 104. Middle East and Africa Gosling Plague Vaccine Sales Market Share in Volume by Country (2024-2033)
Table 105. Middle East and Africa Gosling Plague Vaccine Sales by Country (2024-2033) & (US$ Million)
Table 106. Middle East and Africa Gosling Plague Vaccine Sales Market Share in Value by Country (2024-2033)
Table 107. Qingdao Vland Biotech Company Information
Table 108. Qingdao Vland Biotech Introduction and Business Overview
Table 109. Qingdao Vland Biotech Gosling Plague Vaccine Sales (M Doses), Revenue (Million USD), Price (US$/K Doses) and Gross Margin (2018-2023)
Table 110. Qingdao Vland Biotech Gosling Plague Vaccine Product
Table 111. Qingdao Vland Biotech Recent Development
Table 112. Harbin Pharmaceutical Group Company Information
Table 113. Harbin Pharmaceutical Group Introduction and Business Overview
Table 114. Harbin Pharmaceutical Group Gosling Plague Vaccine Sales (M Doses), Revenue (Million USD), Price (US$/K Doses) and Gross Margin (2018-2023)
Table 115. Harbin Pharmaceutical Group Gosling Plague Vaccine Product
Table 116. Harbin Pharmaceutical Group Recent Development
Table 117. Sinopharm-Vacbio Company Information
Table 118. Sinopharm-Vacbio Introduction and Business Overview
Table 119. Sinopharm-Vacbio Gosling Plague Vaccine Sales (M Doses), Revenue (Million USD), Price (US$/K Doses) and Gross Margin (2018-2023)
Table 120. Sinopharm-Vacbio Gosling Plague Vaccine Product
Table 121. Sinopharm-Vacbio Recent Development
Table 122. JinYu Biotechnology Co., Ltd. Company Information
Table 123. JinYu Biotechnology Co., Ltd. Introduction and Business Overview
Table 124. JinYu Biotechnology Co., Ltd. Gosling Plague Vaccine Sales (M Doses), Revenue (Million USD), Price (US$/K Doses) and Gross Margin (2018-2023)
Table 125. JinYu Biotechnology Co., Ltd. Gosling Plague Vaccine Product
Table 126. JinYu Biotechnology Co., Ltd. Recent Development
Table 127. Jilin Zhengye Biological Product Company Information
Table 128. Jilin Zhengye Biological Product Introduction and Business Overview
Table 129. Jilin Zhengye Biological Product Gosling Plague Vaccine Sales (M Doses), Revenue (Million USD), Price (US$/K Doses) and Gross Margin (2018-2023)
Table 130. Jilin Zhengye Biological Product Gosling Plague Vaccine Product
Table 131. Jilin Zhengye Biological Product Recent Development
Table 132. Key Raw Materials Lists
Table 133. Raw Materials Key Suppliers Lists
Table 134. Gosling Plague Vaccine Market Trends
Table 135. Gosling Plague Vaccine Market Drivers
Table 136. Gosling Plague Vaccine Market Challenges
Table 137. Gosling Plague Vaccine Market Restraints
Table 138. Gosling Plague Vaccine Distributors List
Table 139. Gosling Plague Vaccine Downstream Customers
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
List of Figures
Figure 1. Gosling Plague Vaccine Product Picture
Figure 2. Global Gosling Plague Vaccine Market Size, 2018 VS 2022 VS 2033 (US$ Million)
Figure 3. Global Gosling Plague Vaccine Market Size Status and Outlook (2018-2033) & (US$ Million)
Figure 4. Global Gosling Plague Vaccine Sales Status and Outlook (2018-2033) & (M Doses)
Figure 5. Product Picture of Live Attenuated Vaccines
Figure 6. Global Live Attenuated Vaccines Sales YoY Growth (2018-2033) & (M Doses)
Figure 7. Product Picture of Inactivated Vaccines
Figure 8. Global Inactivated Vaccines Sales YoY Growth (2018-2033) & (M Doses)
Figure 9. Global Gosling Plague Vaccine Sales by Type (2018-2033) & (US$ Million)
Figure 10. Global Gosling Plague Vaccine Sales Market Share by Type in 2022 & 2033
Figure 11. North America Gosling Plague Vaccine Sales Market Share in Volume by Type in 2022
Figure 12. North America Gosling Plague Vaccine Sales Market Share in Value by Type in 2022
Figure 13. Europe Gosling Plague Vaccine Sales Market Share in Volume by Type in 2022
Figure 14. Europe Gosling Plague Vaccine Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Gosling Plague Vaccine Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Gosling Plague Vaccine Sales Market Share in Value by Type in 2022
Figure 17. Latin America Gosling Plague Vaccine Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Gosling Plague Vaccine Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Gosling Plague Vaccine Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Gosling Plague Vaccine Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Gosling Plague Vaccine Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Gosling Plague Vaccine Revenue in 2022
Figure 23. Gosling Plague Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Individual Farming
Figure 25. Global Individual Farming Sales YoY Growth (2018-2033) & (M Doses)
Figure 26. Product Picture of Medium and Large Farms
Figure 27. Global Medium and Large Farms Sales YoY Growth (2018-2033) & (M Doses)
Figure 28. Global Gosling Plague Vaccine Sales by Application (2018-2033) & (US$ Million)
Figure 29. Global Gosling Plague Vaccine Sales Market Share by Application in 2022 & 2033
Figure 30. North America Gosling Plague Vaccine Sales Market Share in Volume by Application in 2022
Figure 31. North America Gosling Plague Vaccine Sales Market Share in Value by Application in 2022
Figure 32. Europe Gosling Plague Vaccine Sales Market Share in Volume by Application in 2022
Figure 33. Europe Gosling Plague Vaccine Sales Market Share in Value by Application in 2022
Figure 34. Asia-Pacific Gosling Plague Vaccine Sales Market Share in Volume by Application in 2022
Figure 35. Asia-Pacific Gosling Plague Vaccine Sales Market Share in Value by Application in 2022
Figure 36. Latin America Gosling Plague Vaccine Sales Market Share in Volume by Application in 2022
Figure 37. Latin America Gosling Plague Vaccine Sales Market Share in Value by Application in 2022
Figure 38. Middle East and Africa Gosling Plague Vaccine Sales Market Share in Value by Application in 2022
Figure 39. Key Raw Materials Price
Figure 40. Gosling Plague Vaccine Manufacturing Cost Structure
Figure 41. Gosling Plague Vaccine Industrial Chain Analysis
Figure 42. Channels of Distribution
Figure 43. Distributors Profiles
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed